Results 171 to 180 of about 127,497 (313)

Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cells. [PDF]

Proc Natl Acad Sci U S A
Mishra A, Abelman RO, Cunneely Q, Putaturo V, Deshpande AA, Bell R, Seider EM, Xu KH, Shan M, Kelly J, Huang SB, Rieur O, Knape J, Gopinathan KA, Kikkeri K, Edd JF, Walsh J, Dai CS, Ellisen LW, Ting DT, Nieman L, Toner M, Bardia A, Haber DA, Maheswaran S.   +24 more
europepmc   +1 more source

Elevated Hemoglobin A2: A Molecular Revisited, and Implications to β‐Thalassemia Screening

Journal of Clinical Laboratory Analysis, EarlyView.
In Thailand, the Hb A2 cut‐off value for β‐thalassemia carrier has been changed from 4.0% to 3.6% since 2015. We examined the molecular basis of β‐thalassemia in a large cohort of Thai subjects with this change. The molecular basis of β‐thalassemia was updated, and a change in the Hb A2 cut‐off can alter this spectrum.
Kritsada Singha, Anupong Pansuwan, Hataichanok Srivorakun, Attawut Chaibunruang, Supawadee Yamsri, Wanicha Tepakhan, Kanokwan Sanchaisuriya, Goonnapa Fucharoen, Supan Fucharoen   +8 more
wiley   +1 more source

Analyzing the Influence of Surgical Sequence on Perioperative Circulating Tumor Cells in Patients with Resectable Non-Small Cell Lung Cancer. [PDF]

Cancer Manag Res
Chen H, He Y, Wang Y, Liu X, Zou G.
europepmc   +1 more source

CTC Regimen [PDF]

, 2020
openaire   +1 more source

Trajectory of irritability in children and youth in Ontario, Canada, throughout the COVID‐19 pandemic

JCPP Advances, EarlyView.
This study explored how irritability in children and youth changed during the COVID‐19 pandemic and its impact on mental health. Results showed a gradual decline in irritability, with factors like age, parental anxiety, and resilience influencing its trajectory.
Theodore C. K. Cheung, Katherine T. Cost, Ronda F. Lo, Evdokia Anagnostou, Catherine S. Birken, Alice Charach, Suneeta Monga, Elizabeth Kelley, Rob Nicolson, Paul D. Arnold, Christie Burton, Daphne J. Korczak, Jennifer Crosbie   +12 more
wiley   +1 more source

Targeting Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma: Rationale, Current Evidence, and a CEACAM6 CAR-T Strategy. [PDF]

Cancers (Basel)
Piejko M, Bak K, Wierciak J, Plutecka H, Wilczynska-Zawal N, Osmola M, Rapacz K, Kijowski J, Mensah-Glanowska P, Szczepanik A, Sierzega M.   +10 more
europepmc   +1 more source

Mapping the Landscape of Over‐Scanning in CT Imaging: A Scoping Review

Journal of Medical Radiation Sciences, EarlyView.
Over‐scanning in CT is highly prevalent and contributes to unnecessary radiation exposure, with notable impact on radiosensitive organs. Standardised protocols and AI‐assisted planning show strong potential to optimise scan range and reduce excess dose.
Mo'men Bani‐Ahmad, Aoife O Sullivan, Yasser H. Hadi, Laura McLaughlin, Andrew England, Mark McEntee   +5 more
wiley   +1 more source

Use of ultrasonography in assessing peri‐implant osseous defects: An in vitro study

Journal of Periodontology, EarlyView.
Abstract Background The purpose of this study is to investigate the feasibility and diagnostic accuracy of ultrasonography in peri‐implant defect identification and evaluation, and to compare ultrasonography (USG) with cone‐beam computed tomography (CBCT) in defect identification and evaluation in an in vitro model.
Melissa Rachel Fok, Alice Yee Ting Kan, Chris Tat Chuen Fok, Ray Tanaka, George Pelekos   +4 more
wiley   +1 more source

Mapping Multi‐Stakeholder Engagement: A Q Methodology in a Regional Project Management Scenario

Strategic Change, EarlyView.
ABSTRACT Research on project management describes the essence of projects involving multiple stakeholders, stressing the value derived from diverse work practices. However, this underestimates issues of counterproductive disagreements associated with diverse groups participating in a project.
Sheng Hu, Amon Simba
wiley   +1 more source

<i>AXL</i>-mRNA Overexpression in Size-Based Enriched Circulating Tumor Cells as a Potential Biomarker for Anti-AXL Targeted Therapies in Non-Small-Cell Lung Cancer. [PDF]

Cancers (Basel)
Ntzifa A, Themistokli E, Strati A, Zavridou M, Tsaroucha E, Sfika A, Psyrri A, Balgouranidou I, Kotsakis A, Georgoulias V, Lianidou E.   +10 more
europepmc   +1 more source